- Teva & Barr Get Super-Sized
- Pfizer--Is It Getting Wiser?
- Lilly's Sex Survey: Will It Have Desired Effect On Cialis?
- Genentech Regenerates Avastin
- Bobby Murcer Remembered
- Elan In Double Trouble?
- Pfizer, Merck And Lilly Partner Up To Get "Enlightened"
- Big Pharma Stocks: Real Rally Or One Day Wonder?
- Cowen's "Elan" For Elan
- UBS And Its Guarded Outlook For Merck's Gardasil
- Web Extra: Your Earnings Edge And More
- Surprise Friday – Who Could It Be?
- The Latest Picks That Paid – Friday July 18th
- The Fast Money Misfires – Friday July 18th
- Pops & Drops: Intel, General Motors...
- The Future Of Wall Street
- Don’t Dump Everything Energy
- Can Apple Save Tech
- Kilduff: Iran Diplomacy = Lower Oil Prices?
- Tomato Growers: Damage From Salmonella Scare Devastating
- Fed's Stern: Hike Rates Sooner Rather Than Later
- Bank Stocks: Fear Trumps Fundamentals
- Week's Rally Still Leaves Some on the Sidelines
- Stock Chatter Focuses on Financials, Pharma
- Freddie Mac Takes Step Toward Issuing Stock
- Defrauded Fund Investors Sue Goldman
- Glum Consumers Focus on Cutting Debt, Savings
- Treasurys Move Lower as Earnings Sap Safety Bid

Pfizer held its shareholder meeting Thursday morning at the Peabody, the historic Memphis hotel where the ducks march through the lobby. I haven't seen the spectacle yet, but I'm told it's quite the scene. 
But it was a smattering of individual investors who were quacking at the meeting here.
One complained about Viagra commercials airing during family-viewing hours and asked Pfizer to follow Eli Lilly's lead to not put Cialis spots on at certain times. Chairman and CEO Jeff Kindler said that as a dad, he's sensitive to that, and wanted to start a dialog with the group the speaker represented.
But a couple of other folks might not have walked away from the microphone as satisfied. They wanted explanations about the declining stock [PFE
Loading...
()
] and assurances it would turn around. At its current price, one PFE exec calculated the stock is paying a 6.5 percent dividend yield. And the handful of investors I talked to before the meeting said the payout is the main reason they're still holding on.
In his opening remarks, Kindler said, "Our progress is not yet reflected in the stock price." You can see his entire prepared statement here.
Reporters weren't allowed inside the meeting. I had to watch it on a closed-circuit feed in a room 20 feet away. I was alone. Meantime, in the ballroom where the meeting was taking place, most of the chairs were empty.
My producer, Ruth, who got to peek in for a minute, counted about a hundred people. Two shareholders said the place would've been jammed if it had been held in New York, where Pfizer is based.
But I did get an exclusive interview with Kindler after he met with the shareholders and his Board and you can watch it here. (See video, above.)
Questions? Comments?





